Roche Launches Melanoma Companion Dx in EU After FDA OK Last Week
August 25, 2011
Roche Launches Melanoma Companion Dx in EU After FDA OK Last Week
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Roche Unveils Higher-Throughput Cobas Systems as it Maps out MDx Strategy
May 23, 2013 / PCR Insider - ARUP Labs Develops Modified Allele-Specific qPCR Assay for BRAF V600E Mutation
January 24, 2013 / PCR Insider - Epizyme Taps Roche to Develop Cobas 4800 CDx for Epizyme/Eisai Lymphoma Drug Candidate
January 10, 2013 / PCR Insider - PGx Highlights from the American Society of Clinical Oncology's 2012 Meeting
June 14, 2012 / Pharmacogenomics Reporter - ASCO Presentations on PGx Melanoma Drugs Portend Crowded Market for BRAF-Mutated Tumors
June 6, 2012 / Pharmacogenomics Reporter